Medpace MEDP 深 沪
已收盘 02-06 16:00:00 美东时间
542.04
+0.770
+0.14%
华盛通- 最 高550.62
- 今 开550.62
- 成交量 75.25万股
- 最 低 539.185
- 昨 收 541.27
- 总市值 152.68亿
- 52周最高 628.9155
- 市盈率 静 42.92
- 换手率 2.67%
- 52周最低 250.05
- 委 比 -23.81%
- 总股本 2816.82万
- 历史最高 628.9155
- 量 比 2.41
- 振 幅 2.11%
- 历史最低 21.76
- 每 手 1
- 风险率 119.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多A Look at Medpace Hldgs's Upcoming Earnings Report
Medpace Hldgs (NASDAQ:MEDP) is preparing to release its quarterly earnings on M...
02-06 22:02
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
Barclays Maintains Underweight on Medpace Hldgs, Raises Price Target to $525
Barclays analyst Luke Sergott maintains Medpace Hldgs (NASDAQ:MEDP) with a Underweight and raises the price target from $485 to $525.
2025-12-16 05:03
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile w...
2025-11-19 01:59
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
2025-11-14 10:43
BMO Capital Initiates Coverage On Medpace Hldgs with Market Perform Rating, Announces Price Target of $600
BMO Capital analyst Sean Dodge initiates coverage on Medpace Hldgs (NASDAQ:MEDP) with a Market Perform rating and announces Price Target of $600.
2025-11-13 17:32
美股大行评级 | 升至45美元！英特尔获多家机构上调目标价；大摩上调拖拉机供应公司(TSCO)评级至"标配"，目标价升至60美元
今日重点评级关注：HC Wainwright & Co.：维持Alto Neuroscience"买入"评级，目标价从10美元升至50美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从110美元升至117美元
2025-10-27 09:45
Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings
Medpace Holdings Inc. (NASDAQ:MEDP) posted better-than-expected third-quarter e...
2025-10-24 21:55
Mizuho Maintains Outperform on Medpace Hldgs, Raises Price Target to $655
Mizuho analyst Ann Hynes maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $575 to $655.
2025-10-24 21:26
